187 related articles for article (PubMed ID: 11218239)
1. Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study.
Jeppesen PB; Szkudlarek J; Høy CE; Mortensen PB
Scand J Gastroenterol; 2001 Jan; 36(1):48-54. PubMed ID: 11218239
[TBL] [Abstract][Full Text] [Related]
2. Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome: a randomized, controlled study.
Scolapio JS
JPEN J Parenter Enteral Nutr; 1999; 23(6):309-12; discussion 312-3. PubMed ID: 10574477
[TBL] [Abstract][Full Text] [Related]
3. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study.
Szkudlarek J; Jeppesen PB; Mortensen PB
Gut; 2000 Aug; 47(2):199-205. PubMed ID: 10896910
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone enhances fat-free mass and glutamine availability in patients with short-bowel syndrome: an ancillary double-blind, randomized crossover study.
Seguy D; Darmaun D; Duhamel A; Thuillier F; Cynober L; Cortot A; Gottrand F; Messing B
Am J Clin Nutr; 2014 Sep; 100(3):850-8. PubMed ID: 25080462
[TBL] [Abstract][Full Text] [Related]
5. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study.
Scolapio JS; Camilleri M; Fleming CR; Oenning LV; Burton DD; Sebo TJ; Batts KP; Kelly DG
Gastroenterology; 1997 Oct; 113(4):1074-81. PubMed ID: 9322500
[TBL] [Abstract][Full Text] [Related]
6. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
[TBL] [Abstract][Full Text] [Related]
7. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial.
Byrne TA; Wilmore DW; Iyer K; Dibaise J; Clancy K; Robinson MK; Chang P; Gertner JM; Lautz D
Ann Surg; 2005 Nov; 242(5):655-61. PubMed ID: 16244538
[TBL] [Abstract][Full Text] [Related]
9. Human growth hormone and glutamine for patients with short bowel syndrome.
Wales PW; Nasr A; de Silva N; Yamada J
Cochrane Database Syst Rev; 2010 Jun; (6):CD006321. PubMed ID: 20556765
[TBL] [Abstract][Full Text] [Related]
10. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study.
Seguy D; Vahedi K; Kapel N; Souberbielle JC; Messing B
Gastroenterology; 2003 Feb; 124(2):293-302. PubMed ID: 12557135
[TBL] [Abstract][Full Text] [Related]
11. Differences in essential fatty acid requirements by enteral and parenteral routes of administration in patients with fat malabsorption.
Jeppesen PB; Høy CE; Mortensen PB
Am J Clin Nutr; 1999 Jul; 70(1):78-84. PubMed ID: 10393142
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.
Jeppesen PB; Hartmann B; Thulesen J; Graff J; Lohmann J; Hansen BS; Tofteng F; Poulsen SS; Madsen JL; Holst JJ; Mortensen PB
Gastroenterology; 2001 Mar; 120(4):806-15. PubMed ID: 11231933
[TBL] [Abstract][Full Text] [Related]
13. Are plasma citrulline and glutamine biomarkers of intestinal absorptive function in patients with short bowel syndrome?
Luo M; Fernández-Estívariz C; Manatunga AK; Bazargan N; Gu LH; Jones DP; Klapproth JM; Sitaraman SV; Leader LM; Galloway JR; Ziegler TR
JPEN J Parenter Enteral Nutr; 2007; 31(1):1-7. PubMed ID: 17202433
[TBL] [Abstract][Full Text] [Related]
14. Growth factors in short-bowel syndrome patients.
Jeppesen PB
Gastroenterol Clin North Am; 2007 Mar; 36(1):109-21, vii. PubMed ID: 17472878
[TBL] [Abstract][Full Text] [Related]
15. Effect of glutamine in short-bowel syndrome.
Scolapio JS; McGreevy K; Tennyson GS; Burnett OL
Clin Nutr; 2001 Aug; 20(4):319-23. PubMed ID: 11478829
[TBL] [Abstract][Full Text] [Related]
16. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet.
Byrne TA; Persinger RL; Young LS; Ziegler TR; Wilmore DW
Ann Surg; 1995 Sep; 222(3):243-54; discussion 254-5. PubMed ID: 7677455
[TBL] [Abstract][Full Text] [Related]
17. The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats.
Gu Y; Wu ZH
World J Gastroenterol; 2002 Aug; 8(4):752-7. PubMed ID: 12174391
[TBL] [Abstract][Full Text] [Related]
18. Beneficial Effects of GH in Young Adults With Prader-Willi Syndrome: A 2-Year Crossover Trial.
Kuppens RJ; Bakker NE; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Donze SH; Festen DA; van Alfen-van der Velden JA; Stijnen T; Hokken-Koelega AC
J Clin Endocrinol Metab; 2016 Nov; 101(11):4110-4116. PubMed ID: 27552545
[TBL] [Abstract][Full Text] [Related]
19. Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.
Ellegård L; Bosaeus I; Nordgren S; Bengtsson BA
Ann Surg; 1997 Jan; 225(1):88-96. PubMed ID: 8998124
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
